![Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI](https://www.ohdsi.org/wp-content/uploads/2020/10/Chan-graphic.png)
Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI
![CardsJC: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes - ISAR-REACT 5 Trial - Cardionerds Twitter Journal Club CardsJC: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes - ISAR-REACT 5 Trial - Cardionerds Twitter Journal Club](https://i0.wp.com/www.cardionerds.com/wp-content/uploads/2022/03/ISAR-REACT-5-Trial-Visual-Abstract-CardioNerds-CardsJC.png?ssl=1)
CardsJC: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes - ISAR-REACT 5 Trial - Cardionerds Twitter Journal Club
![Cas(274693-27-5), Ticagrelor-Aladdin, AR-C 126532XX; AZD 6140;AZD6140;AZD-6140;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol, Cas(274693-27-5), Ticagrelor-Aladdin, AR-C 126532XX; AZD 6140;AZD6140;AZD-6140;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol,](https://www.aladdin-e.com/media/catalog/product/cache/49efc48ad39f6e70be72d36ea561a565/T/1/T125095.png)
Cas(274693-27-5), Ticagrelor-Aladdin, AR-C 126532XX; AZD 6140;AZD6140;AZD-6140;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol,
![Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Meeting Regarding Ticagrelor | Circulation Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Meeting Regarding Ticagrelor | Circulation](https://www.ahajournals.org/cms/asset/b97701db-5f47-47dc-8943-bc5b8e25f12f/zhc0041191320001.jpg)
Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Meeting Regarding Ticagrelor | Circulation
![Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia | JACC: Basic to Translational Science Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia | JACC: Basic to Translational Science](https://www.jacc.org/cms/asset/c5ed37ac-905c-40f0-8713-a1da032c1652/fx1.jpg)
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia | JACC: Basic to Translational Science
![Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines | Gut Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines | Gut](https://gut.bmj.com/content/gutjnl/65/3/374/F1.large.jpg)
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines | Gut
![Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans | Journal of the American College of Cardiology Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/a7a9c084-1778-4d31-be40-8f54b1e8fbf2/gr4.jpg)
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans | Journal of the American College of Cardiology
![Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome | Circulation Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome | Circulation](https://www.ahajournals.org/cms/asset/d339bb41-532f-4a6c-bdbf-4215e7bd9085/circulationaha.120.050645.fig01.gif)